STAT3 and coronary artery disorder: Though we did not notice any significant reduction in the phosphorylation of the STAT-3 transcription factor among preoperative CAD patients (Figure 4A,C), we did observe a marked reduction in the phosphorylation status of STAT-3, but it still had not reached the level of statistical significance among postoperative CAD patients (Figure 4B,D).